Outset Medical (OM) Stock Price, News & Analysis

Company Overview

Outset Medical, Inc. is a medical technology company focused on improving the delivery of hemodialysis. The company develops products intended to simplify dialysis treatment, expand access to care and support the movement of treatment into more convenient clinical and home settings.

Its primary product is the Tablo Hemodialysis System, an integrated dialysis platform designed to automate and streamline the preparation and delivery of treatment. The system combines dialysis hardware, water purification and software-based user guidance in a single platform. Outset also offers related products and services, including mobile equipment and digital tools intended to support Tablo deployment and operation.

Tablo is used in hospitals, outpatient dialysis centers, skilled nursing facilities and other healthcare settings, and has also been cleared for use in the home in the United States. Outset Medical was founded in 2003 and is headquartered in San Jose, California. Leslie Trigg has served as the company’s chief executive officer.

Key Stats

• Today's Range: $3.90 to $4.22
• 50-Day Range: $2.96 to $4.93
• 52-Week Range: $2.84 to $15.94
• Volume: 68,526 shs
• Average Volume: 199,497 shs
• Market Capitalization: $74.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Hold

Outset Medical Stock Analysis - MarketRank™

Outset Medical scored higher than 55% of companies evaluated by MarketBeat, and ranked 426th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Outset Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Outset Medical has a consensus price target of $10.00, representing about 153.8% upside from its current price of $3.94.

Amount of Analyst Coverage

Outset Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Outset Medical are expected to grow in the coming year, from ($3.81) to ($3.01) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Outset Medical is -0.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Outset Medical is -0.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Outset Medical has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.33% of the float of Outset Medical has been sold short.

Short Interest Ratio / Days to Cover

Outset Medical has a short interest ratio ("days to cover") of 5.93.

Change versus previous month

Short interest in Outset Medical has recently decreased by 10.89%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Outset Medical does not currently pay a dividend.

Dividend Growth

Outset Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Outset Medical this week, compared to 2 articles on an average week.

Search Interest

2 people have searched for OM on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Outset Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $46,587.00 in company stock.

Percentage Held by Insiders

2.50% of the stock of Outset Medical is held by insiders.

Percentage Held by Institutions

Outset Medical has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/19/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:OM
• CIK: 1484612
• Web: outsetmedical.com
• Phone: 669-231-8200
• Fax: N/A
• Employees: 310
• Year Founded: 2003

Price Target and Rating

• Average Price Target for Outset Medical: $10.00
• High Price Target: $15.00
• Low Price Target: $7.00
• Potential Upside/Downside: +153.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($4.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$81.65 million
• Net Margins: -63.06%
• Pretax Margin: -62.27%
• Return on Equity: -61.67%
• Return on Assets: -28.25%

Debt

• Debt-to-Equity Ratio: 1.03
• Current Ratio: 5.19
• Quick Ratio: 4.11

Sales & Book Value

• Annual Sales: $119.48 million
• Price / Sales: 0.62
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $6.99 per share
• Price / Book: 0.56

Miscellaneous

• Outstanding Shares: 18,800,000
• Free Float: 18,327,000
• Market Cap: $74.07 million
• Optionable: Not Optionable
• Beta: 1.99